These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3245856)

  • 1. Plasma and urine pharmacokinetics of free and of short-chain carnitine after administration of carnitine in man.
    Segre G; Bianchi E; Corsi M; D'Iddio S; Ghirardi O; Maccari F
    Arzneimittelforschung; 1988 Dec; 38(12):1830-4. PubMed ID: 3245856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption and excretion of L-carnitine during single or multiple dosings in humans.
    Baker H; Frank O; DeAngelis B; Baker ER
    Int J Vitam Nutr Res; 1993; 63(1):22-6. PubMed ID: 8320054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and urine carnitine concentrations in well-trained athletes at rest and after exercise. Influence of L-carnitine intake.
    Nüesch R; Rossetto M; Martina B
    Drugs Exp Clin Res; 1999; 25(4):167-71. PubMed ID: 10442273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.
    Evans AM; Faull R; Fornasini G; Lemanowicz EF; Longo A; Pace S; Nation RL
    Clin Pharmacol Ther; 2000 Sep; 68(3):238-49. PubMed ID: 11014405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Assay of carnitine in plasma and urine of healthy adults].
    Niu YJ; Jiang ZM; Shu H; Li CF; Liu W; Yao GX; Jiang J; Li JQ; Longo A
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):185-7. PubMed ID: 12905800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased tissue distribution of L-carnitine in juvenile visceral steatosis mice.
    Yokogawa K; Higashi Y; Tamai I; Nomura M; Hashimoto N; Nikaido H; Hayakawa J; Miyamoto K; Tsuji A
    J Pharmacol Exp Ther; 1999 Apr; 289(1):224-30. PubMed ID: 10087008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of loxiglumide after single intravenous or oral doses in man.
    Setnikar I; Chisté R; Makovec F; Rovati LC; Warrington SJ
    Arzneimittelforschung; 1988 May; 38(5):716-20. PubMed ID: 3415715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homeostatic equilibrium of L-carnitine family before and after i.v. administration of propionyl-L-carnitine in humans, dogs and rats.
    Marzo A; Cardace G; Corbelleta C; Bassani E; Morabito E; Arrigoni Martelli E
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():357-63. PubMed ID: 1820908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral forms of the oxime HI-6: a study of pharmacokinetics and tolerance after administration to healthy volunteers.
    Jovanovic D; Maksimovic M; Joksovic D; Kovacevic V
    Vet Hum Toxicol; 1990 Oct; 32(5):419-21. PubMed ID: 2238436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma carnitine and acetyl-carnitine levels at different times of the day.
    De Palo E; Gatti R; Crivellaro C; De Palo C; Scandellari C
    Clin Physiol Biochem; 1987; 5(2):95-102. PubMed ID: 3621793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism.
    Rebouche CJ
    Ann N Y Acad Sci; 2004 Nov; 1033():30-41. PubMed ID: 15591001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of etofylline after intravenous and oral administration to humans.
    Zuidema J; Verhoeven J; Merkus FW
    Int J Clin Pharmacol Ther Toxicol; 1981 Jul; 19(7):310-3. PubMed ID: 7263108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free and total carnitine in human serum after oral ingestion of L-carnitine.
    Bach AC; Schirardin H; Sihr MO; Storck D
    Diabete Metab; 1983; 9(2):121-4. PubMed ID: 6617931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition and metabolite kinetics of oral L-carnitine in humans.
    Bain MA; Milne RW; Evans AM
    J Clin Pharmacol; 2006 Oct; 46(10):1163-70. PubMed ID: 16988205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of L-carnitine in biological fluids and tissues.
    Deufel T
    J Clin Chem Clin Biochem; 1990 May; 28(5):307-11. PubMed ID: 2380667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability of carnitine concentrations measured in single postprandial urine samples from dogs.
    Sanderson S; Osborne C; Lulich J; Pierpont ME; Gross K; Ogburn P; Koehler L; Carvalho M
    Am J Vet Res; 1996 Aug; 57(8):1185-8. PubMed ID: 8836372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of acetyl-L-carnitine treatment on the levels of levocarnitine and its derivatives in streptozotocin-diabetic rats.
    Marzo A; Corsico N; Cardace G; Morabito E
    Arzneimittelforschung; 1993 Mar; 43(3):339-42. PubMed ID: 8489564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of propionyl-L-carnitine in humans: evidence for saturable tubular reabsorption.
    Pace S; Longo A; Toon S; Rolan P; Evans AM
    Br J Clin Pharmacol; 2000 Nov; 50(5):441-8. PubMed ID: 11069438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased formation of short-chain organic acids after chronic ethanol administration and its interaction with the carnitine pool in rat.
    Calabrese V; Calvani M; Butterfield DA
    Arch Biochem Biophys; 2004 Nov; 431(2):271-8. PubMed ID: 15488476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.